The Communication Initiative Network
Where communication and media are central to social and economic development
Knowledge SectionsE-magazinesThe CI PartnersClassifiedsAbout UsUpcoming Events |
Average Rating: no ratings submitted
Understanding the Results of the AIDSVAX TrialPublication DateMay 14 2003 (This version will be updated by AVAC as more information becomes available) SummaryIn late February 2003, the world heard preliminary results of the first large scale human trial of a vaccine designed to prevent HIV infection.The results for the overall trial cohort were clear and disappointing. The results for a relatively small subset of trial participants are less clear, and they have sparked controversy and require further analysis. This brochure, published by AIDS Vaccine Advocacy Coalition (AVAC), aims to help readers understand what is known and what is not known about the experimental vaccine known as AIDSVAX.
AIDS Vaccine Advocacy Coalition (AVAC) is dedicated to accelerating the ethical development and global delivery of vaccines against AIDS. AVAC does not accept funding from government or the pharmaceutical industry. PublisherNumber of Pages11 ContactAIDS Vaccine Advocacy Coalition (AVAC)
101 West 23rd St. #2227 New York, NY 10011 USA Tel.: (212) 367-1279 avac@avac.org AVAC website SourceA posting to the SEA-AIDS discussion with a subject of "Resource: Highlights of AIDS Vaccine Research" on July 3 2006. Placed on the Communication Initiative site July 05 2006 Last Updated July 05 2006 |
Register and ParticipateUser loginHelp Seed The CI Network
Discuss!PollDevelopment News |
Save & Share This Page
Social Bookmarks